Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2012 - 2026)

Enanta Pharmaceuticals (ENTA) has 15 years of Interest Coverage Ratio data on file, last reported at 1.54 in Q1 2026.

• Quarterly Interest Coverage Ratio rose 89.23% year-over-year to 1.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.85 (down 200.54% YoY) and the FY2025 annual result came in at 0.6, up 94.23% from the prior year.
• Interest Coverage Ratio improved to 1.54 in Q1 2026, from 3.65 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.21 in Q2 2025 to a low of 18.38 in Q2 2023.
• A 5-year average of 5.3 and a median of 2.22 in 2025 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 6335.9% — and 2024, when it jumped 96.11%.
• Tracing ENTA's Interest Coverage Ratio over 5 years: stood at 1.7 in 2022, then slumped by 496.15% to 10.14 in 2023, then increased by 22.8% to 7.83 in 2024, then surged by 53.37% to 3.65 in 2025, then surged by 57.78% to 1.54 in 2026.
• The last three Interest Coverage Ratio figures came in at 1.54 (Q1 2026), 3.65 (Q4 2025), and 2.22 (Q3 2025), per Business Quant data.